로딩 중…
지수 로딩 중…
SAMIL PHARMACEUTICAL CO.,LTD
000520· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩6,910-1.99%
2026-06-19
Price Chart
SAMIL PHARMACEUTICAL CO.,LTD-31.65%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 149.89B KRW |
| Revenue | 210.51B KRW |
| Net Income | -36.42B KRW |
| Total Assets | 372.34B KRW |
| Net Assets | 128.56B KRW |
| Employees | 593 |
| Value | |
| P/B | 1.17x |
| P/S | 0.71x |
| FCF Yield | -4.60% |
| Profitability | |
| ROE | -28.33% |
| ROA | -9.78% |
| Op. Margin | -5.50% |
| Revenue Growth | 0.50% |
| Financial Health | |
| Debt Ratio | 189.63% |
| Total Debt | 163.89B KRW |
| FCF | -6.89B KRW |
| Cash | 1.19B KRW |
| Current Ratio | 0.46x |
| Performance | |
| 1Y Return | -31.65% |
| 1M Return | -11.86% |
| From 52W High | -46.27% |
| 1Y MDD | -45.12% |
| Trading | |
| Volume | 127,584 shares |
| Foreign Own. | 3.85% |
| Per Share | |
| EPS | -1,679 KRW |
| BPS | 6,016 KRW |
Company Info
Samil Pharmaceutical, a mid-sized pharmaceutical company established in 1947 and listed on KOSPI in 1985, primarily develops, produces, and sells specialized and generic pharmaceuticals. The company also exclusively distributes directly imported original products in Korea. It operates a subsidiary with a global ophthalmic CDMO factory in Vietnam and has secured domestic sales rights for new drugs from Galmed and Biosplice. Samil Pharmaceutical is pursuing growth in new drug development and global CDMO business, headquartered in Seocho-gu, Seoul.